Oral Acyclovir Therapy for Mucocutaneous Herpes Simplex Virus Infections in Immunocompromised Marrow Transplant Recipients
Authors:
- David H. SheppDSDavid H. Shepp
- Barbara A. NewtonBNBarbara A. Newton
- Paula S. DandlikerPDPaula S. Dandliker
- Nancy FlournoyNFNancy Flournoy
- Joel D. MeyersJMJoel D. Meyers
- 1 June 1985
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 102 (6) , 783-785
Abstract
In a randomized, double-blinded, placebo-controlled trial, we compared the therapeutic effect of oral acyclovir (400 mg five times daily for 10 days) with that of placebo in patients with marrow transplants and culture-proven recurrent mucocutaneous herpes simplex. Twelve patients received acyclovir and nine received placebo. Acyclovir treatment significantly shortened the median duration of viral shedding, new lesion formation, and time to first decrease in pain, resolution of pain, 50% healing, and total healing. These results compared favorably with those previously obtained with intravenous or topical acyclovir preparations. Oral acyclovir is highly effective for the treatment of recurrent mucocutaneous infections caused by herpes simplex virus in immunocompromised patients.Keywords
This publication has 14 references indexed in Scilit:
- Infections Caused by Herpes Simplex Virus in the Immunocompromised Host: Natural History And Topical Acyclovir TherapyThe Journal of Infectious Diseases, 1984
- Oral acyclovir prophylaxis against herpes simplex virus in non-Hodgkin lymphoma and acute lymphoblastic leukaemia patients receiving remission induction chemotherapy. A randomised double blind, placebo controlled trialBritish Journal of Cancer, 1984
- A Double-Blind Study of Oral Acyclovir for Suppression of Recurrences of Genital Herpes Simplex Virus InfectionNew England Journal of Medicine, 1984
- Suppression of Frequently Recurring Genital HerpesNew England Journal of Medicine, 1984
- Oral Acyclovir for Prevention of Herpes Simplex Virus Reactivation After Marrow TransplantationAnnals of Internal Medicine, 1984
- Oral administration of cyclosporin A for recipients of allogeneic marrow transplants: implications of clinical gut dysfunctionBritish Journal of Haematology, 1984
- Treatment of First Episodes of Genital Herpes Simplex Virus Infection with Oral AcyclovirNew England Journal of Medicine, 1983
- Acyclovir for Chronic Mucocutaneous Herpes Simplex Virus Infection in Immunosuppressed PatientsAnnals of Internal Medicine, 1982
- Intravenous Acyclovir to Treat Mucocutaneous Herpes Simplex Virus Infection After Marrow TransplantationAnnals of Internal Medicine, 1982
- A sensitive radioimmunoassay for the antiviral agent BW248U [9-(2-hydroxyethoxymethyl)guanine]Analytical Biochemistry, 1979